People have been flushing salt water through their nose on purpose for thousands of years. Jala neti, the yogic nasal-cleansing practice, predates modern medicine by centuries, and a version of it now sits in nearly every pharmacy as neti pots, squeeze bottles, and saline spray cans promising relief from a stuffy nose or a sinus infection. For most of that history, the practice ran almost entirely on tradition and plausibility rather than rigorous testing. Then COVID-19 gave a research group that was already building a case that salt water does something real to viruses in the nose a reason to finally put the idea through a proper trial. What came back is more complicated, and more interesting, than either side of the salt-water debate usually admits.
What Salt Water Actually Does Inside Your Nose
The nose's main defense against inhaled viruses, bacteria, and debris is a system called mucociliary clearance. A layer of mucus sits on top of millions of hair-like cilia that beat in a coordinated wave, sweeping that mucus, and whatever it trapped, toward the back of the throat to be swallowed. Saline solution helps this system in several measurable ways, documented across a range of lab and clinical studies. It rehydrates the mucus layer when it has dried out, which happens easily in cold air, heated indoor air, or during an infection. It changes the physical properties of mucus enough to reduce how many virus-carrying droplets get aerosolized when a person coughs or sneezes afterward. And in cell-culture experiments, saline at concentrations close to what's in a nasal rinse bottle directly slowed the replication of SARS-CoV-2 in infected cells, likely through several overlapping mechanisms involving chloride ions and an enzyme called myeloperoxidase that salt helps convert into a mild, naturally occurring disinfectant (Huijghebaert, Hoste, & Vanham, 2021).
That's a real, well-documented set of mechanisms, but it comes with a wrinkle that rarely makes it into the marketing. A review of how different nasal irrigation solutions affect the cilia themselves found a genuine contradiction in the literature: pushing the salt concentration past isotonic levels often speeds up how fast mucus clears out in bulk, which is what most people actually care about, but it can simultaneously slow down or even briefly stop the individual cilia from beating, measured directly under a microscope (Jiao & Zhang, 2019). More salt, in other words, is not simply better in a straight line. Researchers still don't fully agree on why bulk clearance and ciliary beat frequency sometimes move in opposite directions, a reminder that "it's just salt water" undersells how biologically active this remedy actually is.
What Decades of Cochrane Reviews Found
The clinical trial evidence is where the story gets less satisfying than the mechanism would predict. The Cochrane Collaboration, which runs some of the most conservative systematic reviews in medicine, has looked at saline nasal irrigation for acute upper respiratory infections twice. The first review, in 2010, found three usable trials covering 618 people and concluded the evidence was too thin and too low quality to draw confident conclusions, beyond a hint of benefit in adults and a note that 40 percent of babies in one trial wouldn't tolerate saline nose drops at all (Kassel, King, & Spurling, 2010). An updated version five years later added two more trials, bringing the total to 544 children and 205 adults, and reached much the same place: most outcomes showed no real difference between saline and standard care. The one exception was a single larger pediatric trial that found a statistically significant reduction in nasal secretion and nasal obstruction scores, but the reviewers were upfront that the actual size of that improvement, about a third of a point on a four-point symptom scale, was probably too small to matter much to a sick child or their parent (King, Mitchell, Williams, & Spurling, 2015). Their bottom line, essentially unchanged across both reviews: nasal saline possibly helps a little, nobody has run a trial strong enough to be confident about it, and future researchers need to stop running small, inconsistent studies and do one properly.
COVID Gave This Research a Reason to Get Serious
The most compelling push to actually run a properly sized trial came from an Edinburgh research team with a specific, falsifiable idea: that chloride ions in salt water help nasal and throat cells produce a natural disinfectant, and that irrigating and gargling with strong, hypertonic saline early in a cold might meaningfully cut down how much virus a sick person sheds. In 2019, they published a small pilot trial testing exactly that in otherwise healthy adults who'd just caught a common cold. The results looked striking for a trial that size: people who rinsed and gargled with 3 percent saline recovered about two days faster on average, used 36 percent less over-the-counter medication, and were 35 percent less likely to pass the infection on to someone else in their household, compared with people managing their cold as they normally would (Ramalingam, Graham, Dove, Morrice, & Sheikh, 2019). It was unblinded and had no placebo arm; the researchers argued a convincing placebo didn't really exist, since even plain saline might carry some of the same chloride-based effect they were testing for. The authors said plainly that this was a pilot, not proof, and called for a larger trial.
They got the chance to run essentially that same test at a much bigger scale once COVID-19 arrived, and the result flipped. A pragmatic trial of 576 adults with suspected or confirmed COVID-19 in Pakistan, led by several of the same investigators, compared hypertonic saline nasal irrigation and gargling against an active control: a ritual nasal wash and gargle already practiced before Muslim prayers, chosen specifically to be culturally appropriate and genuinely comparable rather than an inert placebo. On the trial's strict primary measure, complete and sustained symptom resolution, there was essentially no difference at all: about 3.6 percent of the saline group and 3.7 percent of the control group hit that mark (Yusuf et al., 2024). A softer secondary measure, reaching a mild symptom level rather than being fully symptom-free, did favor the saline group significantly, which keeps the door open rather than shutting it. But on the question the trial was actually built and powered to answer, salt water did not outperform a tap-water rinse. The authors' own conclusion was blunt: they could not recommend the treatment for people already five days into their illness, and said a trial starting within the first 48 hours, closer to how the original pilot was designed, still needs to be run.
That reversal is worth sitting with for a moment, because it cuts against a common failure mode in health reporting, where a promising pilot study gets treated as settled and nobody checks back once the bigger trial actually runs. Here, the same research program ran both studies, got a different answer the second time within a few years, and published the disappointing result instead of quietly moving on. That's closer to how this is supposed to work.
The Smaller Studies in Between
A handful of other trials sit in the gap between the Cochrane reviews and the two COVID-era trials, and they don't resolve the picture so much as add texture to it. A Thai-led randomized trial of large-volume saline irrigation in adults with acute rhinosinusitis found no overall benefit across the whole study group, but a subgroup analysis suggested a real improvement specifically in patients whose rhinosinusitis was triggered by a common cold rather than other causes, an effect that didn't show up in the full sample (Chitsuthipakorn et al., 2021). That's the kind of subgroup finding that deserves a healthy dose of skepticism on its own, since slicing a dataset into smaller groups after the fact tends to turn up some positive-looking result by chance, and it would need its own dedicated trial to confirm.
An Italian study on COVID-19 patients illustrates a different kind of complication. Researchers compared people who did daily isotonic saline lavages against a historical group of patients from roughly a year earlier who hadn't, and found real, statistically significant improvements in blocked nose, sneezing, and runny nose in the treated group (Spinato et al., 2021). But the study also reported that 91 percent of the treated group tested negative for the virus by day 10, versus under 3 percent of the untreated comparison group, a gap so large it's a far more plausible sign of changing testing practices and circumstances between two different phases of the pandemic than of a nasal rinse. It's a useful illustration of why a historical control group, patients from an earlier time period rather than people randomized at the same time, is one of the weaker forms of evidence in this literature, even when the symptom-level findings themselves look reasonable on their own.
A better-controlled pediatric trial out of Shanghai, running during the Omicron BA.2 wave, randomized 403 children with mild or asymptomatic infection to seawater nasal irrigation or standard care, and found the treated children cleared detectable virus about 0.7 days faster on average, with the effect concentrated in children who weren't fully vaccinated (Lin et al., 2023). It's a genuinely well-designed trial for this literature, though a three-quarter-day difference in viral shedding is a modest, mechanistic result, not the same thing as proof that the children recovered from illness any faster.
Rinsing a Child's Nose Is Its Own Question
Most of the trial evidence above involves adults or school-age children capable of irrigating their own nose. Infants and toddlers are a different situation, and a recent pediatric-focused review lays out why plainly: young children have proportionally narrower nasal passages, can't reliably clear secretions on their own, and often can't tolerate the standard high-volume squeeze-bottle technique at all, which is why low-volume drops or sprays are the default tool for the youngest patients even though they probably clear less mucus than a full irrigation would (Pecoraro et al., 2026). The review's overall read on the pediatric trial evidence lines up with the adult Cochrane reviews: generally positive but methodologically thin, with real, if modest, support for use in acute colds, sinusitis, and allergic rhinitis in children.
Safety, done right, is genuinely good. The review reports that properly performed saline irrigation has a strong safety record in children, with side effects limited mostly to mild, temporary nasal discomfort or stinging. The real risk sits almost entirely in how the solution is prepared: using non-sterile tap water instead of sterile, distilled, or previously boiled and cooled water carries a real contamination risk, which is why guidelines on this treat solution purity, not just technique, as the safety-critical step. A short, specific list of situations call for caution or avoidance altogether, including a skull-base fracture with cerebrospinal fluid leakage, significant swallowing difficulties, and active nosebleeds or recent facial trauma, worth knowing if nasal irrigation ever comes up for someone outside the straightforward case of an otherwise healthy person with a stuffy nose.
A Possible Upgrade, Still Just in Mice
If plain saline has real but modest and sometimes contradictory effects on the cilia, an obvious next question is whether a different solution could do the job more cleanly. One early candidate is sodium hyaluronate, the same hyaluronic acid used in skincare, formulated as a nasal spray. A 2026 study tested it against standard saline in mice repeatedly exposed to an allergen, and found the hyaluronate spray did a noticeably better job preserving the protective fluid layer on the nasal lining, kept mucus-producing cells healthier, and slowed the decline in mucociliary clearance compared with saline over a week of exposure (Zhao et al., 2026). That's a genuinely interesting mechanistic result, worth flagging here mainly to make a point by contrast with everything above it: this is a mouse study of allergen exposure, not a human trial of anything, and the distance between a promising finding in a mouse's nose and a usable recommendation for a person's is exactly the distance this whole article has been walking through for plain salt water, on time scales of years and against considerably more scrutiny.
The Takeaway
Salt water does something real and measurable inside the nose: it rehydrates mucus, helps the cilia clear it, and even slows viral replication directly under lab conditions. None of that is marketing fluff. What the clinical trial evidence adds up to, though, is messier and more honest than either "ancient wisdom, obviously works" or "it's just salt water, does nothing" allows for. Decades of Cochrane reviews describe a probable small benefit that nobody has nailed down with a genuinely strong trial. The best single piece of recent evidence, a large, carefully designed COVID-19 trial from a research group that had every reason to want a positive result, came back negative on the question it was built to answer, and the researchers published that outcome plainly instead of burying it. Smaller studies in between point in different directions depending on the population and how the comparison was set up. None of this means nasal rinsing is useless. It's cheap, generally very safe when done with clean water and sensible technique, and the mechanism behind it is genuine. It just means the confident claims on either side of this debate are running ahead of what the actual trials, read carefully and together, can support.
Sources
- Huijghebaert, S., Hoste, L., & Vanham, G. (2021). Essentials in saline pharmacology for nasal or respiratory hygiene in times of COVID-19. European Journal of Clinical Pharmacology, 77(9), 1275-1293. https://doi.org/10.1007/s00228-021-03102-3
- Jiao, J., & Zhang, L. (2019). Influence of intranasal drugs on human nasal mucociliary clearance and ciliary beat frequency. Allergy, Asthma & Immunology Research, 11(3), 306-319. https://doi.org/10.4168/aair.2019.11.3.306
- Kassel, J. C., King, D., & Spurling, G. K. (2010). Saline nasal irrigation for acute upper respiratory tract infections. Cochrane Database of Systematic Reviews, (3), CD006821. https://doi.org/10.1002/14651858.CD006821.pub2
- King, D., Mitchell, B., Williams, C. P., & Spurling, G. K. P. (2015). Saline nasal irrigation for acute upper respiratory tract infections. Cochrane Database of Systematic Reviews, 2015(4), CD006821. https://doi.org/10.1002/14651858.CD006821.pub3
- Ramalingam, S., Graham, C., Dove, J., Morrice, L., & Sheikh, A. (2019). A pilot, open labelled, randomised controlled trial of hypertonic saline nasal irrigation and gargling for the common cold. Scientific Reports, 9(1), 1015. https://doi.org/10.1038/s41598-018-37703-3
- Yusuf, O. M., Ramalingam, S., Norrie, J., Graham, C., Kakakhail, A., Rextin, A. T., Baig, R. T., Yusuf, S. O., Ahmad, B., Zahra, S., & Sheikh, A. (2024). Hypertonic saline nasal irrigation and gargling for suspected or confirmed COVID-19: Pragmatic randomised controlled trial (ELVIS COVID-19). Journal of Global Health, 14, 05027. https://doi.org/10.7189/jogh.14.05027
- Chitsuthipakorn, W., Thanaphiphatsatja, A., Doungbuppha, P., Lawpoolsri, S., Seresirikachorn, K., & Snidvongs, K. (2021). Effects of large volume, isotonic nasal saline irrigation for acute rhinosinusitis: A randomized controlled study. International Forum of Allergy & Rhinology, 11(10), 1424-1435. https://doi.org/10.1002/alr.22807
- Spinato, G., Fabbris, C., Costantini, G., Conte, F., Scotton, P. G., Cinetto, F., De Siati, R., Matarazzo, A., Citterio, M., Contro, G., De Filippis, C., Agostini, C., Emanuelli, E., Boscolo-Rizzo, P., & Frezza, D. (2021). The effect of isotonic saline nasal lavages in improving symptoms in SARS-CoV-2 infection: A case-control study. Frontiers in Neurology, 12, 794471. https://doi.org/10.3389/fneur.2021.794471
- Lin, J.-L., Zhang, F., Li, Y.-B., Yuan, S.-H., Wu, J.-H., Zhang, J., Zhang, L., He, Y., Chen, J., & Yin, Y. (2023). Efficacy of physiological seawater nasal irrigation for the treatment of children with SARS-CoV-2 Omicron BA.2 variant infection: A randomized controlled trial. World Journal of Pediatrics, 20(5), 461-469. https://doi.org/10.1007/s12519-023-00749-z
- Pecoraro, L., Dell'Anna, A., Di Muri, E., Altavilla, E., Marasciulo, F., Signore, A., & Indrio, F. (2026). Nasal irrigation in children: From pathophysiological rationale to clinical practice. Children, 13(7), 851. https://doi.org/10.3390/children13070851
- Zhao, W., Lang, J., Wang, Y., Sun, L., Li, J., Meng, C., & Zhu, D. (2026). Protective effects of sodium hyaluronate nasal spray on murine nasal mucosa via preservation of airway surface liquid and mucociliary clearance. Frontiers in Allergy, 7, 1866527. https://doi.org/10.3389/falgy.2026.1866527